It inhibits BRCC36 by sequestering the catalytic Zn2+ ion within the enzyme’s active site, thereby disrupting the BRCC36-HMGCR interaction and suppressing HCC cell growth. Here, HMGCR is linked to hepatocellular carcinoma.